Antao Dai
Impact in
-
- Neuropeptides and Animal Physiology
-
- Diabetes Treatment and Management
Papers in
-
- Neuropeptides and Animal Physiology 21
-
- Diabetes Treatment and Management 19
- Co-authors
- Dehua YangMing‐Wei WangXiaoqing CaiHong YangQingtong ZhouShiping YangHe HuRaymond C. Stevens
In The Last Decade
Antao Dai
44 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Cellular and Molecular Neuroscience 613
- Endocrinology, Diabetes and Metabolism 310
- Molecular Biology 1.2k
- Biomaterials 232
- Endocrine and Autonomic Systems 89
Countries citing papers authored by Antao Dai
This map shows the geographic impact of Antao Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antao Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antao Dai more than expected).
Fields of papers citing papers by Antao Dai
This network shows the impact of papers produced by Antao Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antao Dai. The network helps show where Antao Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Antao Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 25 | |
| 4 | 2021 | 25 | |
| 5 | 2021 | 60 | |
| 6 | 2021 | 96 | |
| 7 | 2021 | 40 | |
| 8 | 2021 | 30 | |
| 9 | 2020 | 110 | |
| 10 | 2020 | 5 | |
| 11 | 2020 | 32 | |
| 12 | 2020 | 25 | |
| 13 | 2020 | 40 | |
| 14 | Common activation mechanism of class A GPCRs Hit paper breakdown → | 2019 | 396 |
| 15 | 2018 | 42 | |
| 16 | 2016 | 45 | |
| 17 | 2016 | 51 | |
| 18 | 2013 | 71 | |
| 19 | 2011 | 234 | |
| 20 | 2011 | 20 |
About Antao Dai
Antao Dai is a scholar working on Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism, Molecular Biology, Endocrine and Autonomic Systems and Nutrition and Dietetics, having authored 45 papers that have together received 1.8k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (31 papers), Neuropeptides and Animal Physiology (21 papers), Diabetes Treatment and Management (19 papers), Computational Drug Discovery Methods (4 papers), Biochemical Analysis and Sensing Techniques (4 papers), Characterization and Applications of Magnetic Nanoparticles (3 papers), Regulation of Appetite and Obesity (3 papers) and Mass Spectrometry Techniques and Applications (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (613 citations), Endocrinology, Diabetes and Metabolism (310 citations), Molecular Biology (1.2k citations), Biomaterials (232 citations) and Endocrine and Autonomic Systems (89 citations). Antao Dai has collaborated with scholars based in China, Japan and Australia. Frequent co-authors include Dehua Yang, Ming‐Wei Wang, Xiaoqing Cai, Hong Yang, Qingtong Zhou, Shiping Yang, He Hu, Raymond C. Stevens, Suwen Zhao and Zhi‐Jie Liu. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Cell Research, Acta Pharmacologica Sinica and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.